MONTEREY, Calif. — MicroPulse transscleral laser therapy delivered with a functionally and ergonomically revised probe resulted in a greater IOP-lowering effect while maintaining the safety profile of the original, according to a poster.
“We were comparing the original probe vs. the revised probe for MicroPulse transscleral laser therapy, and we found better IOP-lowering effect with the revised probe compared to the original probe,“ Maya Ramachandran, BA, told Healio/OSN at the Women in Ophthalmology Summer Symposium, where the WIO-Top Glaucoma Poster was presented.
Working